je.st
news
Tag: research
It takes a research army to reach unstoppable levels
2016-12-05 20:44:00| National Hog Farmer
We are facing a growing consumer community that fears technology. Unfortunately, consumers fears trump all other concerns, especially when it comes to food. Excellent research is often tossed aside if communication surrounding the new innovation or practice is broken. read more
Tags: research
takes
levels
reach
Research finds microbial traits, not plants, determine abundance of soil organic matter
2016-12-05 17:02:00| Corn & Soybean Digest
University of New Hampshire Researchers at the University of New Hampshire paints a completely different pathway to building soil organic matter. Soil carbon, in my mind, is the fulcrum around which all aspects of soil revolve, says a former New Hampshire researcher. read more
Tags: research
determine
matter
plants
Research Ties Sow and Progeny Diet to Kyphosis Risk
2016-12-05 01:00:00| ThePigSite - Industry News
US - Research from the University of Wisconsin has given pork producers some things to consider when identifying and mitigating the causes of kyphosis, a condition characterized by an abnormal, outward spinal curvature in pigs. While the causes for the condition remain unclear, the research has demonstrated a dietary connection to kyphosis.
Research ties sow and progeny diet to kyphosis risk
2016-12-02 17:17:00| National Hog Farmer
Research from the University of Wisconsin has given pork producers some things to consider when identifying and mitigating the causes of kyphosis, a condition characterized by an abnormal, outward spinal curvature in pigs. read more
New KEYTRUDA (pembrolizumab) Data to be Presented at 17th World Conference on Lung Cancer Highlight Research Across the Spectrum of Thoracic Malignancies
2016-11-30 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Findings to be Presented in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Malignant Pleural Mesothelioma with KEYTRUDA as Monotherapy and in Combination with Other Treatments Quality of Life Data from KEYNOTE-024 in First-Line Non-Small Cell Lung Cancer to be Presented in Plenary Session KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, across multiple thoracic malignancies, including non-small cell lung cancer (NSCLC), small cell lung cancer and malignant pleural mesothelioma, will be presented at the 17th World Conference on Lung Cancer (WCLC) hosted by the International Association for the Study of Lung Cancer in Vienna, Austria, Dec. Language: English Contact: Media Contacts:Pamela Eisele, (267) 305-3558orKim Hamilton, (908) 740-1863orInvestor Contacts:Teri Loxam, (908) 740-1986orAmy Klug, (908) 740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] next »